Valuation: Embracing Future Holdings Limited

Market Cap 45.07M 35.2M 31.53M 29.09M 26.32M 49.22M 3.35B 50.02M 347M 138M 1.75B 132M 129M 5.56B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 46.93M 36.65M 32.83M 30.28M 27.41M 51.25M 3.49B 52.08M 361M 144M 1.83B 138M 135M 5.79B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 day-3.85%
1 week+4.17%
Current month-26.47%
1 month-26.47%
3 months-30.56%
6 months-46.81%
Current year-51.92%
1 week 0.02
Extreme 0.023
0.03
1 month 0.02
Extreme 0.023
0.04
Current year 0.02
Extreme 0.023
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.22
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 2024-04-29
Comptroller/Controller/Auditor 44 2024-06-30
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 2021-06-13
Director/Board Member 55 2023-03-30
Director/Board Member 70 2023-11-26
Date Insider Type Main position Quantity % Market Cap. Importance
4/30/21 Exercice

Chairman

330,000 0.1250%
8/19/20 Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
-3.85%+4.17%+8.70%+92.31% 35.14M
+0.71%+4.82%+27.02%+64.39% 260B
+1.24%+3.15%+10.73%+26.13% 165B
+1.03%+1.11%-16.52%+73.28% 154B
+0.61%-7.22%-57.44%-13.79% 61.49B
+2.90%+4.83%+14.21%+53.04% 52.9B
+0.70%+2.71%-13.09%-6.48% 52.84B
-2.35%-3.79%+8.26%+63.75% 51.46B
-0.18%+4.18%+26.50%+76.27% 51.16B
+0.67%+5.37%+39.77%+96.14% 46.85B
Average +0.15%-0.10%+4.81%+52.50% 89.57B
Weighted average by Cap. +0.76%+2.42%+7.18%+50.97%

Financials

2024 2025
Net sales 858K 670K 600K 554K 501K 937K 63.81M 952K 6.61M 2.64M 33.4M 2.51M 2.46M 106M 5.26M 4.11M 3.68M 3.4M 3.07M 5.75M 391M 5.84M 40.51M 16.16M 205M 15.42M 15.09M 649M
Net income -3.43M -2.68M -2.4M -2.22M -2.01M -3.75M -255M -3.81M -26.44M -10.55M -134M -10.07M -9.85M -423M -3.96M -3.09M -2.77M -2.56M -2.31M -4.33M -295M -4.4M -30.51M -12.17M -154M -11.61M -11.37M -488M
Net Debt 1.46M 1.14M 1.02M 939K 850K 1.59M 108M 1.61M 11.2M 4.47M 56.63M 4.26M 4.17M 179M 1.86M 1.45M 1.3M 1.2M 1.08M 2.03M 138M 2.06M 14.29M 5.7M 72.24M 5.44M 5.32M 229M
Projected Income Statement - Annual - Embracing Future Holdings Limited
Logo Embracing Future Holdings Limited
Embracing Future Holdings Ltd, formerly Biolidics Limited, is a precision medicine medical technology company. Its principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
-
Date Price Change Volume
26-10-29 SGD 0.0250 -3.85% 100,000
26-10-27 SGD 0.0260 0.00% 3,502,200
26-10-26 SGD 0.0260 +8.33% 23,100
26-10-23 SGD 0.0240 -11.11% 2,027,300
26-10-22 SGD 0.0270 -12.90% 1,258,800